Background: The understanding of the specific role of sympathetic neural control and dysregulation in lower extremities arterial disease (LEAD) is still very limited. Aim of our study was to investigate the autonomic profile in LEAD patients and to evaluate if the eventual autonomic alterations were more severe in patients with advanced disease. Methods: We enrolled all consecutive outpatients with LEAD referred to our Departments between July 2012 and September 2014. They were compared to a group of matched outpatients without LEAD. All patients underwent Holter ECG monitoring. Time-domain analysis of heart rate variability (HRV) was evaluated. Results: Compared to controls, patients with LEAD had a lower SDNN (P=0.007) and SDANN (P=0.003). Patients with clinically advanced LEAD had a lower SDNN (P=0.006) and SDANN (P=0.004) compared to LEAD patients with less severe disease and to those without disease. Conclusions: LEAD patients had a reduced SDNN and SDANN than patients without LEAD. Autonomic dysfunction was more significant in clinically advanced stages of disease. This association did not relate to ABI value but to clinical stage of disease.

ButtÀ, C., Tuttolomondo, A., Casuccio, A., DI Raimondo, D., Miceli, G., Cuttitta, F., et al. (2021). Autonomic dysfunction in a group of lower extremities arterial disease outpatients. MINERVA CARDIOLOGY AND ANGIOLOGY, 69(1), 28-35 [10.23736/S2724-5683.20.05094-X].

Autonomic dysfunction in a group of lower extremities arterial disease outpatients

Tuttolomondo, Antonino;Casuccio, Alessandra;DI Raimondo, Domenico;Miceli, Giuseppe;Zappulla, Valentina;Corpora, Francesca;Pinto, Antonio
Ultimo
2021

Abstract

Background: The understanding of the specific role of sympathetic neural control and dysregulation in lower extremities arterial disease (LEAD) is still very limited. Aim of our study was to investigate the autonomic profile in LEAD patients and to evaluate if the eventual autonomic alterations were more severe in patients with advanced disease. Methods: We enrolled all consecutive outpatients with LEAD referred to our Departments between July 2012 and September 2014. They were compared to a group of matched outpatients without LEAD. All patients underwent Holter ECG monitoring. Time-domain analysis of heart rate variability (HRV) was evaluated. Results: Compared to controls, patients with LEAD had a lower SDNN (P=0.007) and SDANN (P=0.003). Patients with clinically advanced LEAD had a lower SDNN (P=0.006) and SDANN (P=0.004) compared to LEAD patients with less severe disease and to those without disease. Conclusions: LEAD patients had a reduced SDNN and SDANN than patients without LEAD. Autonomic dysfunction was more significant in clinically advanced stages of disease. This association did not relate to ABI value but to clinical stage of disease.
ButtÀ, C., Tuttolomondo, A., Casuccio, A., DI Raimondo, D., Miceli, G., Cuttitta, F., et al. (2021). Autonomic dysfunction in a group of lower extremities arterial disease outpatients. MINERVA CARDIOLOGY AND ANGIOLOGY, 69(1), 28-35 [10.23736/S2724-5683.20.05094-X].
File in questo prodotto:
File Dimensione Formato  
R05Y2021N01A0028.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 578.56 kB
Formato Adobe PDF
578.56 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/540761
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact